Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Trial Profile

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2015

At a glance

  • Drugs Antithrombin alfa (Primary)
  • Indications Embolism and thrombosis; Surgical blood loss
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jul 2015 Status changed from suspended to discontinued as per ClinicalTrials.gov record.
    • 05 May 2013 New source identified and integrated (Mayo Clinic: 11-004125).
    • 29 Apr 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top